Clin2
NCT07835633Possibly a fitRecruiting

Safety study of a single injection of ACC085 in healthy adults

Healthy Adult Participants

This trial tests a new medication called ACC085 given as a single injection to healthy adults. The goal is to find out how safe it is and how the body processes it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
47 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 18 and 55 years old.
  • Your body mass index (BMI) must be between 18.5 and 27.
  • You must be in good general health, with no serious or chronic illnesses.
  • You must not have taken any prescription or over-the-counter drugs (including herbal medicines) in the 2 weeks before the study starts.
  • You must have no history of drug or alcohol abuse, and you must not smoke more than 10 cigarettes per day.
  • You must be willing to use effective birth control if you or your partner can have children, from 1 month before the study until 1 year after the injection.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07818915Not yet recruiting· Phase 1
Safety study of an experimental medication in healthy adults

This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.

NCT07790783Not yet recruiting· Phase 1
Healthy volunteer study of a new injection (phase 1)

This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.

Beijing, Beijing Municipality
NCT07432698Not yet recruiting· Phase 1
Safety study of AK0406 injection in healthy adults

This study tests a new medicine called AK0406, given as an injection, to see if it is safe and how the body handles it in healthy volunteers. It helps find the right dose for future studies.

Bayswater, Victoria
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch

Hear when a new Healthy Adult Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.